Editas Medicine, Inc.
EDIT
$1.28
$0.010.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -45.40M | -62.14M | -67.61M | -61.95M | -18.87M |
| Total Depreciation and Amortization | 1.38M | 1.60M | 1.42M | 1.41M | 1.47M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.35M | 3.62M | 2.72M | 5.87M | 3.26M |
| Change in Net Operating Assets | -12.10M | 4.34M | 6.41M | 4.80M | -8.09M |
| Cash from Operations | -50.76M | -52.59M | -57.06M | -49.87M | -22.24M |
| Capital Expenditure | -540.00K | -2.92M | -3.49M | -1.87M | -1.31M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31.50M | 86.90M | 55.45M | -2.87M | 64.15M |
| Cash from Investing | 30.96M | 83.98M | 51.95M | -4.75M | 62.84M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 269.00K | 0.00 | 322.00K | 192.00K | 514.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 55.24M | -- | -- | -- | -- |
| Cash from Financing | 55.51M | 0.00 | 322.00K | 192.00K | 514.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 35.71M | 31.39M | -4.79M | -54.43M | 41.11M |